New Disorders Workgroup Winter Webinar Series Part Three: On the Horizon: A Review of Up and Coming Disorders and the Future of the RUSP

Date: February 18, 2021 2:00 pm EST

DESCRIPTION
The Association of Public Health Laboratories (APHL) Newborn Screening Technical assistance and Evaluation Program (NewSTEPs) is pleased to announce the final webinar in the New Disorders Workgroup Winter Webinar Series. This three-part webinar series provides updates from programs screening for disorders not currently on the RUSP, both as pilot programs and as components of universal screening. This series ends with a discussion of future disorders that have been nominated for review by the Advisory Committee on Heritable Disorders in Newborns and Children (ACHDNC) and/or are in current pilots.

This webinar highlights disorders that are on the horizon for possible RUSP nomination and present both research and advocacy efforts in expanding newborn screening for additional disorders. This webinar helps programs prepare for potential upcoming disease additions.  


OBJECTIVES

At the conclusion of the program, the participant will be able to:

  • Review disorders on the horizon for RUSP nomination
  • Describe current research and pilot activities around these disorders
  • Review Metachromatic Leukodystrophy (MLD) RUSP nomination activities and ScreenPlus pilot activities
  • Discuss future recommendations for RUSP nomination

Please use this link to register for the webinar.  

SPEAKERS

Amy Brower, PhD,
Associate Director, American College of Medical Genetics and Genomics
Joe Orsini, PhD, Director of Operations, New York State Newborn Screening Program
Andreas Rohrwasser, PhD, MBA,  Newborn Screening Laboratory Director, Utah Department of Health 
Dean Suhr, President and Co-Founder, MLD Foundation

CONTINUING EDUCATION

APHL is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E® Program, Florida and CPH recertification. P.A.C.E® is accepted by all licensure states except Florida. If approved, this webinar will provide 1.0 contact hour for participants who successfully complete this webinar.


This resource is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) under grant # U22MC24078. This information or content and conclusions are those of the authors and should not be construed as the official position or policy of, nor should any endorsements be inferred by HRSA, HHS or the US Government.

Tags